Agriculture And Food Tenders

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Infliximab (Atc Code According to Who: L04ab02)

Building Cleaning - Maintenance and Basic Cleaning

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Iron (Ii) Sulfate (B03aa07) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Eptinezumab (N02cd05) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Pimecrolimus (D11ah02) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Tolvaptan (G04bx21) as Part of a So-Called Open House Model.

Rv to Provide Prevention Measures in Accordance with Sections 20 Ff Sbg V, Oh Procedure

Medicines with the Active Ingredient Tacrolimus (Atc: L04ad02)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Iron (Ii) Sulfate (B03aa07) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Fingolimod (L04ae01) as Part of a So-Called Open House Model.